A Phase II/III Trial Of Neoadjuvant Folfox, With Selective Use Of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiatio
Posted Date: May 15, 2019
- Investigator: Olugbenga Olowokure
- Type of Study: Drug
Alliance N1048
Criteria:
To Be Eligible To Participate In This Study, Patients Must Have Cancer Of The Rectum.
Keywords:
Gastrointestinal, N1048, Phase Ii, Phase Iii, Rectal Cancer
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com